Niagen Bioscience (NAGE) Operating Income Growth (3y) (2014 - 2026)
Niagen Bioscience (NAGE) Operating Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | - |
| 10 | Niagen Bioscience | 256.13 Mn | 189.58 Mn | 19.98 Mn | 40.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.96% |
| Dec 31, 2025 | 69.03% |
| Sep 30, 2025 | 50.10% |
| Jun 30, 2025 | 35.70% |
| Mar 31, 2025 | 37.81% |
| Dec 31, 2024 | 49.44% |
| Sep 30, 2024 | 29.69% |
| Jun 30, 2024 | 64.15% |
| Mar 31, 2024 | 53.69% |
| Dec 31, 2023 | 69.77% |
| Sep 30, 2023 | 35.10% |
| Jun 30, 2023 | 14.36% |
| Mar 31, 2023 | 30.61% |
| Dec 31, 2022 | 45.38% |
| Sep 30, 2022 | 23.66% |
| Jun 30, 2022 | 3.83% |
| Mar 31, 2022 | 2.62% |
| Dec 31, 2021 | 13.59% |
| Sep 30, 2021 | -0.94% |
| Jun 30, 2021 | 11.22% |